ASTONEA LABS LIMITED (BSE: 544409) is a Panchkula, Haryana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹373 Cr, it ranks #2,186 by market cap among the 6,197 Indian listed companies on FinBizNet, and #30 of 63 in Pharmaceuticals. At ₹350.00 (as of 16 Nov 2026), the share price is 5.1% below its 52-week high of ₹369.00 and 155.4% above its 52-week low of ₹137.05. The share price is up 118.9% over one year and up 25.9% over three months.
| Current Price | ₹350.00 |
|---|---|
| Market Cap | ₹373 Cr |
| BSE Code | 544409 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 79.1 |
| Return on Assets | 4.43% |
| 52-Week Range | ₹137.05 – ₹369.00 |
| 1-Year Price Change | +118.9% |
| 3-Month Price Change | +25.9% |
| Beta (1Y) | 0.12 |
| Headquarters | Panchkula, Haryana |
| Website | www.astonea.org/ |
Delivery averaged 100.0% of traded volume across 5 BSE sessions (30 Oct 2026 – 13 Nov 2026).
Astonea Labs Limited manufactures and markets pharmaceutical and cosmetic products under the Glow Up, Avicel, and Regero brand names in India and internationally. The company offers pharmaceutical products, including generics, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as cosmetic and personal care products, such as skincare, haircare, anti-aging, ethical, and organic cosmetic lines. It offers its products in tablets, capsules, softgels, soaps, oral and external powders, ointments, aerosols, creams, and lotions, as well as toothpastes and mouthwashes. Astonea Labs Limited was incorporated in 2017 and is based in Panchkula, India.
1. Manufacture and Sale of Drugs & Cosmetics-This segment manufactures and markets pharmaceutical and cosmetic products. It offers antibiotic drugs, anti-cold medications, and antihistamines; and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, and fungal infections, as well as multivitamins. 2. NA-NA 3. NA-NA 4. NA-NA
1. Manufacture and Sale of Drugs & Cosmetics-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹56,531 Cr | 36.3 | 34.46% | ₹1,814 Cr | -8.1% |
| Emcure Pharmaceuticals Ltd | ₹42,344 Cr | 47.9 | 19.57% | ₹2,820 Cr | +73.3% |
| Ajanta Pharma Limited | ₹41,474 Cr | 39.4 | 25.39% | ₹1,794 Cr | +27.8% |
| Piramal Pharma Ltd | ₹32,600 Cr | n/m | -4.00% | ₹2,617 Cr | +22.8% |
| RUBICON RESEARCH LIMITED | ₹28,526 Cr | 112.3 | 19.14% | ₹576 Cr | +162.7% |
| Caplin Point Laboratories Ltdte | ₹18,155 Cr | 28.3 | 19.94% | ₹630 Cr | +23.6% |
| Pfizer Ltd. | ₹17,811 Cr | 24.5 | 17.16% | ₹727 Cr | -24.2% |
| Eris Lifesciences Ltd | ₹17,691 Cr | 28.3 | 18.07% | ₹892 Cr | -17.5% |
| ASTONEA LABS LIMITED | ₹373 Cr | 79.1 | — | — | +118.9% |
Listed by market capitalisation. Ratios are shown for context only.
ASTONEA LABS LIMITED is trading at ₹350.00, with a market capitalisation of ₹373 Cr.
ASTONEA LABS LIMITED operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
ASTONEA LABS LIMITED has a P/E of 79.1.
ASTONEA LABS LIMITED is listed on the BSE under the scrip code 544409.
ASTONEA LABS LIMITED's share price is up 118.9% over one year and up 25.9% over three months. Its 52-week range is ₹137.05 to ₹369.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.